Multiple Myeloma
Multiple myeloma is a type of blood cancer that affects plasma cells, leading to the production of abnormal proteins and causing issues like bone pain and kidney problems.
Long-Term Follow-Up of CAR T-Cell Therapy Patients
We are studying the long-term effects and safety of CAR T-cell therapy in patients who have received this treatment. This includes monitoring for delayed side effects and the persistence of modified T-cells in the blood.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
B-cell Lymphoma
B-cell lymphoma is a type of cancer that originates in B-cells, a part of the immune system, and can lead to swollen lymph nodes and other systemic symptoms.
B-cell Type Acute Leukaemia
B-cell type acute leukaemia is a fast-growing cancer of the blood and bone marrow that affects B-cells, leading to symptoms like fatigue and increased bleeding.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Have you received CAR-T therapy from Novartis or Penn sponsored treatment trials?
- Have you received CAR-T therapy as part of a managed access program (MAP) by Novartis?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Phe885
Ytb323
Rapcabtagene Autoleucel
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Department of Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology
Salzburg, Austria
Medical University Of Vienna
Department of Internal Medicine I, Division of Haematology and Haemostaseology
Vienna, Austria
St. Anna Kinderspital GmbH
Division of Haematology and Oncology
Vienna, Austria
Sponsor: Novartis Pharma Services AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.